KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $430.3 million.

  • Hims & Hers Health's Operating Expenses rose 4559.51% to $430.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 5998.64%. This contributed to the annual value of $1.1 billion for FY2024, which is 4927.85% up from last year.
  • As of Q3 2025, Hims & Hers Health's Operating Expenses stood at $430.3 million, which was up 4559.51% from $389.5 million recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's Operating Expenses peaked at $430.3 million during Q3 2025, and registered a low of $64.7 million during Q2 2021.
  • For the 5-year period, Hims & Hers Health's Operating Expenses averaged around $202.4 million, with its median value being $179.4 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 23034.99% in 2021, then surged by 340.53% in 2022.
  • Hims & Hers Health's Operating Expenses (Quarter) stood at $83.7 million in 2021, then surged by 72.05% to $143.9 million in 2022, then skyrocketed by 42.04% to $204.5 million in 2023, then skyrocketed by 71.65% to $350.9 million in 2024, then increased by 22.6% to $430.3 million in 2025.
  • Its Operating Expenses stands at $430.3 million for Q3 2025, versus $389.5 million for Q2 2025 and $372.8 million for Q1 2025.